• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    L3Harris Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    4/30/25 4:31:40 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials
    Get the next $LHX alert in real time by email
    hrs-20250428
    0000202058false00002020582025-04-282025-04-28

    l3harrislogopra34.jpg
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): April 28, 2025
    L3HARRIS TECHNOLOGIES, INC.
    (Exact name of registrant as specified in its charter)
    Delaware
    1-386334-0276860
    (State or other jurisdiction
     of incorporation)
    (Commission
     File Number)
    (I.R.S. Employer
     Identification No.)
    1025 West NASA Boulevard
    Melbourne,Florida 32919
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (321) 727-9100
    No change
    (Former name or former address, if changed since last report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $1.00 per shareLHXNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
     Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
    ☐









    Item 8.01    Other Events.

    On April 28, 2025, Christopher E. Kubasik, Chair and Chief Executive Officer of L3Harris Technologies, Inc. (the “Company”), established a written pre-arranged plan providing for the exercise of certain employee stock options and the sale of shares of the Company’s common stock issued upon exercise of such options (the “Plan”). The Plan has been adopted under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company’s policies regarding transactions in the Company’s securities by executives and was established during the Company’s open trading window. In accordance with Rule 10b5-1, Mr. Kubasik will have no discretion over sales under the Plan.
    The Plan covers vested options to purchase up to 147,411 shares granted to Mr. Kubasik in 2017, which options expire in 2027. Subject to minimum price thresholds specified in the Plan, shares underlying unexercised options will be sold on predetermined dates starting in July of 2025 and ending no later than September 9, 2025. Mr. Kubasik’s ownership interest in the Company is considerably in excess of the Company’s stock ownership guidelines. Transactions under the Plan will be disclosed publicly through Form 4 and Form 144 filings, as applicable, with the U.S. Securities and Exchange Commission.

    Except as may be required in the Company’s periodic filings on Form 10-Q or Form 10-K, the Company does not undertake to report any Rule 10b5-1 plans that may be adopted by any other officers or directors of the Company or to report modifications or termination of any such plans, including the Plan.

    Item 9.01 Financial Statements and Exhibits.

         (d) Exhibits.

     The following exhibits are provided herewith:
    Exhibit
    Number
    Description                                                                                                                              
    104Cover Page Interactive Data File formatted in Inline XBRL
    1


    SIGNATURE
         Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    L3HARRIS TECHNOLOGIES, INC.
    By:/s/ Christoph T. Feddersen
    Name:Christoph T. Feddersen
    Date: April 30, 2025Title:Vice President, General Counsel and Secretary

    2
    Get the next $LHX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LHX

    DatePrice TargetRatingAnalyst
    4/11/2025$263.00Sell → Buy
    Goldman
    1/8/2025$289.00 → $267.00Mkt Perform → Outperform
    Bernstein
    1/2/2025Outperform → Mkt Perform
    Raymond James
    11/26/2024$300.00Hold → Buy
    Argus
    10/31/2024$300.00Neutral → Buy
    BofA Securities
    10/10/2024$300.00Peer Perform → Outperform
    Wolfe Research
    8/14/2024$250.00 → $240.00Outperform → Sector Perform
    RBC Capital Mkts
    8/9/2024$275.00 → $257.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings